| Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis SP McAdoo, N Medjeral-Thomas, S Gopaluni, A Tanna, N Mansfield, ... Nephrology Dialysis Transplantation 34 (1), 63-73, 2019 | 165 | 2019 |
| A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody–associated vasculitis RJ Pepper, SP McAdoo, SM Moran, D Kelly, J Scott, S Hamour, A Burns, ... Rheumatology 58 (2), 260-268, 2019 | 137 | 2019 |
| Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis A Kronbichler, J Kerschbaum, S Gopaluni, J Tieu, F Alberici, RB Jones, ... Annals of the rheumatic diseases 77 (10), 1440-1447, 2018 | 132 | 2018 |
| Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized … S Gopaluni, RM Smith, M Lewin, CA McAlear, K Mynard, RB Jones, ... Trials 18, 1-6, 2017 | 90 | 2017 |
| B cell therapy in ANCA-associated vasculitis: current and emerging treatment options M McClure, S Gopaluni, D Jayne, R Jones Nature Reviews Rheumatology 14 (10), 580-591, 2018 | 75 | 2018 |
| Interventions for chronic kidney disease-associated restless legs syndrome (Review) S Gopaluni, M Sherif, NA Ahmadouk Cochrane Database of Systematic Reviews, 2016 | 70 | 2016 |
| Rituximab associated hypogammaglobulinemia in autoimmune disease J Tieu, RM Smith, S Gopaluni, DS Kumararatne, M McClure, A Manson, ... Frontiers in immunology 12, 671503, 2021 | 67 | 2021 |
| Evaluation of PR3-ANCA status after rituximab for ANCA-associated vasculitis ME McClure, J Wason, S Gopaluni, J Tieu, RM Smith, DR Jayne, ... JCR: Journal of Clinical Rheumatology 25 (5), 217-223, 2019 | 43 | 2019 |
| Risk factors for severe outcomes in patients with systemic vasculitis and COVID‐19: a binational, registry‐based cohort study MA Rutherford, J Scott, M Karabayas, M Antonelou, S Gopaluni, D Gray, ... Arthritis & Rheumatology 73 (9), 1713-1719, 2021 | 40 | 2021 |
| The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study J Wagner, EM Harrison, M Martinez Del Pero, B Blane, G Mayer, J Leierer, ... Microbiome 7, 1-17, 2019 | 29 | 2019 |
| Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models ME McClure, Y Zhu, RM Smith, S Gopaluni, J Tieu, T Pope, KE Kristensen, ... Rheumatology 60 (3), 1491-1501, 2021 | 28 | 2021 |
| Effect of Disease Activity at Three and Six Months After Diagnosis on Long‐Term Outcomes in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis S Gopaluni, O Flossmann, MA Little, P O'Hara, P Bekker, D Jayne, ... Arthritis & Rheumatology 71 (5), 784-791, 2019 | 26 | 2019 |
| Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome G Trivioli, S Gopaluni, ML Urban, D Gianfreda, MA Cassia, PG Vercelloni, ... Clinical kidney journal 14 (1), 332-340, 2021 | 22 | 2021 |
| A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts O Karadag, A Erden, Y Bilginer, S Gopaluni, A Sari, B Armagan, I Ertenli, ... Rheumatology International 38 (10), 1833-1840, 2018 | 22 | 2018 |
| Superior vena cava obstruction presenting with epistaxis, haemoptysis and gastro-intestinal haemorrhage in two men receiving haemodialysis with central venous catheters: two … S Gopaluni, P Warwicker Journal of medical case reports 3, 1-3, 2009 | 20 | 2009 |
| Alemtuzumab for refractory primary systemic vasculitis—a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE) S Gopaluni, R Smith, D Goymer, H Cahill, E Broadhurst, E Wallin, ... Arthritis Research & Therapy 24 (1), 81, 2022 | 19 | 2022 |
| Acute kidney injury in the critically ill patient S Gopaluni, S Lines, AJP Lewington Current Anaesthesia & Critical Care 21 (2), 60-64, 2010 | 17 | 2010 |
| Clinical trials in vasculitis S Gopaluni, D Jayne Current Treatment Options in Rheumatology 2, 161-177, 2016 | 11 | 2016 |
| The sound of interconnectivity; the European vasculitis society 2022 report AC Egan, A Kronbichler, I Neumann, A Bettiol, N Carlson, MC Cid, ... Kidney International Reports 7 (8), 1745-1757, 2022 | 7 | 2022 |
| 302. ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS–A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL S Gopaluni, D Goymer, M McClure, H Cahill, E Broadhurst, R Smith, ... Rheumatology 58 (Supplement_2), kez063. 026, 2019 | 7 | 2019 |
